Sun On ‘Disciplined’ M&A Approach, Day 1 Launch Readiness For Semaglutide In India

 
• By Anju Ghangurde
  
Sun reinforces M&A strategy amid speculated interest in Organon (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from India

More from Scrip